By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ampio Pharmaceuticals, Inc. 

5445 DTC Parkway, P4

Greenwood Village  Colorado  80111  U.S.A.
Phone: 303-418-1000 Fax: 303-418-1001


SEARCH JOBS


Industry
Pharmaceutical






Company News
Ampio Pharmaceuticals, Inc. (AMPE) Updates Status Of Clinical Trials And Manufacturing Facility 11/12/2014 8:15:12 AM
Ampio Pharmaceuticals, Inc. (AMPE) Could Have A Blockbuster Fourth Quarter, Says Citi 10/29/2014 1:06:04 PM
Ampio Pharmaceuticals, Inc. (AMPE) Announces Results Of The Open Label Portion Of The Multiple Intra-Articular Injections (MI) Study Of Ampion™ In Patients With Osteoarthritis Of The Knee At Week Twelve Of The Trial 10/17/2014 7:19:35 AM
Wall Street Shouldn't Write Off Ampio Pharmaceuticals, Inc. (AMPE) Yet: Citi Analysts 9/16/2014 2:21:24 AM
Ampio Pharmaceuticals, Inc. (AMPE) Announces Webcast For Annual Shareholder Meeting 9/15/2014 10:09:24 AM
Ampio Pharmaceuticals, Inc. (AMPE) Release: Update On The Phase 3 Multicenter, Double-Blind STEP Study Of Ampion™ For Osteoarthritis Of The Knee 9/2/2014 1:30:35 PM
Letter To The Ampio Pharmaceuticals, Inc. (AMPE) Shareholders In Regard To The STEP Study And Ampio's Plans For The Ampion™ BLA 8/25/2014 10:19:48 AM
Ampio Pharmaceuticals, Inc. (AMPE) Reports That Due To Temperature Deviations Below Product Specifications During Shipments To The Ampion™ STEP Study Clinical Sites, Release Of Data Will Be Delayed 8/21/2014 7:32:26 AM
Ampio Pharmaceuticals, Inc. (AMPE) Release: Analysis Of Available Data From Optimeyes Study (Blinded And Open Label) Of Optina™ For The Treatment Of Diabetic Macular Edema (DME) Indicates Potential For Significant Clinical Benefit 8/20/2014 7:31:30 AM
Ampio Pharmaceuticals, Inc. (AMPE) Touts Very Positive Data For Ampion Osteoarthrtis Study 8/18/2014 6:20:52 AM
12345678910...
//-->